AstraZeneca’s COVID-19 shot scores European authorization as production holdups linger esagonowsky Fri, 01/29/2021 – 13:41 More: AstraZeneca's COVID-19 shot scores European authorization as production holdups linger Source: fierce
read moreWCLC: With Keytruda-Yervoy data, Merck casts doubt on Opdivo’s place in lung cancer aliu Fri, 01/29/2021 – 12:18 More: WCLC: With Keytruda-Yervoy data, Merck casts doubt on Opdivo's place in lung cancer Source: fierce
read moreEli Lilly’s COVID-19 antibody picks up $871M in Q4—and carries blockbuster hopes for 2021 esagonowsky Fri, 01/29/2021 – 10:51 More: Eli Lilly's COVID-19 antibody picks up 1M in Q4—and carries blockbuster hopes for 2021 Source: fierce
read moreMerck earmarks $10 million to improve U.S. maternal health equity sharon.coey Fri, 01/29/2021 – 10:43 More: Merck earmarks million to improve U.S. maternal health equity Source: fierce
read moreAlmirall enlists Happify to boost psoriasis patients’ mental health with digital therapeutics bbulik Fri, 01/29/2021 – 10:41 More: Almirall enlists Happify to boost psoriasis patients' mental health with digital therapeutics Source: fierce
read moreGBT is aiming for the approval of Oxbryta to treat haemolytic anaemia in patients with sickle cell disease More: EMA begins review of GBT's sickle cell treatment Oxbryta Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals